137 related articles for article (PubMed ID: 26864752)
1. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype.
Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M
Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752
[TBL] [Abstract][Full Text] [Related]
2. MEF2C deletions and mutations versus duplications: a clinical comparison.
Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
[TBL] [Abstract][Full Text] [Related]
3. Microdeletion 5q14.3 and anomalies of brain development.
Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
[TBL] [Abstract][Full Text] [Related]
4. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
[TBL] [Abstract][Full Text] [Related]
5. Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report.
Yauy K; Schneider A; Ng BL; Gaillard JB; Sati S; Coubes C; Wells C; Tournaire M; Guignard T; Bouret P; Geneviève D; Puechberty J; Pellestor F; Gatinois V
BMC Med Genomics; 2019 Aug; 12(1):116. PubMed ID: 31375103
[TBL] [Abstract][Full Text] [Related]
6. Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus: a recurrent clinical finding.
Al-Shehhi M; Betts D; Mc Ardle L; Donoghue V; Reardon W
Clin Dysmorphol; 2016 Jan; 25(1):23-6. PubMed ID: 26426104
[No Abstract] [Full Text] [Related]
7. Chromosome Xq28 duplication encompassing MECP2: Clinical and molecular analysis of 16 new patients from 10 families in China.
Yi Z; Pan H; Li L; Wu H; Wang S; Ma Y; Qi Y
Eur J Med Genet; 2016 Jun; 59(6-7):347-53. PubMed ID: 27180140
[TBL] [Abstract][Full Text] [Related]
8. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature.
Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C
Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
[TBL] [Abstract][Full Text] [Related]
10. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
11. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
[TBL] [Abstract][Full Text] [Related]
12. ADGRV1 is implicated in myoclonic epilepsy.
Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
[TBL] [Abstract][Full Text] [Related]
13. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
[TBL] [Abstract][Full Text] [Related]
14. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.
Carr CW; Zimmerman HH; Martin CL; Vikkula M; Byrd AC; Abdul-Rahman OA
Am J Med Genet A; 2011 Jul; 155A(7):1640-5. PubMed ID: 21626678
[TBL] [Abstract][Full Text] [Related]
15. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?
Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A
Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179
[TBL] [Abstract][Full Text] [Related]
16. Inherited duplication of the short arm of chromosome 18p11.32-p11.31 associated with developmental delay/intellectual disability.
Balasubramanian M; Sithambaram S; Smith K
Clin Dysmorphol; 2016 Jan; 25(1):19-22. PubMed ID: 26287558
[TBL] [Abstract][Full Text] [Related]
17. De novo duplication of 17p13.1-p13.2 in a patient with intellectual disability and obesity.
Kuroda Y; Ohashi I; Tominaga M; Saito T; Nagai J; Ida K; Naruto T; Masuno M; Kurosawa K
Am J Med Genet A; 2014 Jun; 164A(6):1550-4. PubMed ID: 24668897
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
[TBL] [Abstract][Full Text] [Related]
19. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of a 3.2-Mb 2p16.1-p15 duplication associated with familial intellectual disability.
Chen CP; Chern SR; Wu PS; Chen SW; Lai ST; Chuang TY; Chen WL; Yang CW; Wang W
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):578-582. PubMed ID: 30122582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]